|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, MDS Panel
Test Code902199
CPT Codes
88271 (x13), 88275 (x7)<br>Restricted Client Code
Includes
FISH, MDS/Myeloid Panel, -5/5q-,-7/7q-, +8,20q-
FISH, KMT2A (Lysine Methyltransferase 2A) Gene Rearrangement
FISH, Chromosome, D13S319, Deletion 13q14
FISH, Myeloid Neoplasms, MECOM (EVI1), 3q26.2
FISH, p53, Deletion 17p13.1
FISH, KMT2A (Lysine Methyltransferase 2A) Gene Rearrangement
FISH, Chromosome, D13S319, Deletion 13q14
FISH, Myeloid Neoplasms, MECOM (EVI1), 3q26.2
FISH, p53, Deletion 17p13.1
Preferred Specimen
See the individual tests for specimen requirements and stabilities
Instructions
Clinical history/reason for referral is required with test order. Prior therapy and transplant history should be provided with test order.
Specimen Stability
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not reject.
Methodology
Fluorescence In Situ Hybridization
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 15 days
Reference Range
See individual tests

